The Michael J. Fox Foundation Annual Report 2017 – Roadmaps for Progress | Page 10

The Michael J. Fox Foundation

Annual Letter from the CEO and the Co-Founder

Todd Sherer, PhD,( right) with David Standaert, MD, PhD, at the annual PD Therapeutics Conference
Debi Brooks with Michael J. Fox at an MJFF salon sharing research progress
Dear Friend,
Understanding Parkinson’ s disease is the starting point of every effort to accelerate the cure. Years of work spent uncovering Parkinson’ s secrets— defining the highly variable patient experience, shedding light on genetic origins of disease, mapping molecular pathways— are now paying off in a tangibly quickening tempo of progress. Researchers are increasingly linking pathology to clinical symptoms( and vice versa) to inform therapeutic target and biomarker identification.
4